Submit Deal

Submit Deal

Cover Image Mark Lampert

Mark Lampert

Founder and CEO at BVF PARTNERS

Investor

Deal Bio

Total Deals17

Valued Deals17

Total Value£ 4.19 B

Avg. Deal Size£ 246 M

Market Context

Sort

28 Oct 2020|United States|Biotechnology

Target: MIRAGEN THERAPEUTICS

Bidder: VENROCK

16 Service Providers

5 Target | 11 Bidder

19 Dealmakers

5 Target | 14 Bidder

£ 70 M

Value

05 Jan 2021|United States|Biotechnology

Target: IKENA ONCOLOGY

Bidder: OMEGA FUNDS

15 Service Providers

3 Target | 12 Bidder

15 Dealmakers

3 Target | 12 Bidder

£ 88 M

Value

10 Feb 2021|United States|Biotechnology

Target: DAY ONE BIOPHARMACEUTICALS

Bidder: RA CAPITAL MANAGEMENT

11 Service Providers

2 Target | 9 Bidder

11 Dealmakers

2 Target | 9 Bidder

£ 94 M

Value

16 Feb 2021|United Kingdom|Pharmaceuticals

Target: CENTESSA PHARMACEUTICALS

Bidder: JANUS HENDERSON INVESTORS

20 Service Providers

5 Target | 15 Bidder

27 Dealmakers

9 Target | 19 Bidder

£ 179 M

Value

06 Aug 2021|United States|Pharmaceuticals

Target: EQRX

Bidder: BVF PARTNERS

27 Service Providers

6 Target | 21 Bidder

53 Dealmakers

6 Target | 49 Bidder

£ 2.62 B

Value

12 Oct 2021|United States|Biotechnology

Target: CINCOR PHARMA

Bidder: BVF PARTNERS

15 Service Providers

2 Target | 13 Bidder

19 Dealmakers

4 Target | 15 Bidder

£ 104 M

Value

20 Oct 2021|China|Pharmaceuticals

Target: SHOUTI

Bidder: CASDIN CAPITAL

21 Service Providers

3 Target | 18 Bidder

20 Dealmakers

2 Target | 18 Bidder

£ 72 M

Value

04 Oct 2021|Switzerland|Biotechnology

Target: MOONLAKE IMMUNOTHERAPEUTICS

Bidder: BVF PARTNERS

25 Service Providers

7 Target | 18 Bidder

44 Dealmakers

11 Target | 34 Bidder

£ 169 M

Value

09 Feb 2022|Canada|Pharmaceuticals

Target: VENTUS THERAPEUTICS

Bidder: ANDREESSEN HOROWITZ LLC (A16Z)

12 Service Providers

3 Target | 9 Bidder

12 Dealmakers

2 Target | 10 Bidder

£ 103 M

Value

13 Jun 2022|United States|Biotechnology

Target: ELEKTROFI

Bidder: JANUS HENDERSON INVESTORS

8 Service Providers

3 Target | 5 Bidder

10 Dealmakers

2 Target | 8 Bidder

£ 32 M

Value

14 Dec 2022|Canada|Biotechnology

Target: ALPHA-9 THERANOSTICS

Bidder: QUARK VENTURE

8 Service Providers

1 Target | 7 Bidder

11 Dealmakers

1 Target | 10 Bidder

£ 60 M

Value

22 May 2023|United States|Biotechnology

Target: QUANTA THERAPEUTICS

Bidder: VIDA VENTURES

11 Service Providers

3 Target | 8 Bidder

11 Dealmakers

3 Target | 8 Bidder

£ 40 M

Value

11 Jul 2023|United States|Biotechnology

Target: SEPTERNA

Bidder: RA CAPITAL MANAGEMENT

19 Service Providers

3 Target | 16 Bidder

19 Dealmakers

3 Target | 16 Bidder

£ 116 M

Value

11 Jul 2023|United States|Biotechnology

Target: CROSSBOW THERAPEUTICS

Bidder: MIRAE ASSET VENTURE INVESTMENT

8 Service Providers

2 Target | 6 Bidder

9 Dealmakers

3 Target | 6 Bidder

£ 62 M

Value

24 Jan 2023|United States|Pharmaceuticals

Target: VERASTEM

Bidder: BVF PARTNERS

3 Service Providers

1 Target | 2 Bidder

4 Dealmakers

2 Target | 2 Bidder

£ 48 M

Value

24 Apr 2024|United States|Biotechnology

Target: CIDARA THERAPEUTICS

Bidder: RA CAPITAL MANAGEMENT

7 Service Providers

1 Target | 6 Bidder

8 Dealmakers

2 Target | 6 Bidder

£ 193 M

Value

23 Jul 2024|United States|Biotechnology

Target: THIRD ARC BIO

Bidder: VIDA VENTURES

15 Service Providers

1 Target | 14 Bidder

14 Dealmakers

1 Target | 13 Bidder

£ 127 M

Value

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite